Company intelligence / Profile preview
Corepharm Bio
Seoul, South Korea
- Ownership
- Private
- Employees
- ~60
- Development stage
- Other
01
Overview
Corepharm Bio is a South Korean specialty pharmaceutical company that specializes in the development of incrementally modified drugs (IMDs) through innovative drug delivery systems. The company is best known for its expertise in Central Nervous System (CNS) disorders, particularly for developing the world's first donepezil orally disintegrating tablet (ODT) for Alzheimer's disease. Corepharm Bio utilizes proprietary platform technologies, including ODT and transdermal drug delivery systems (TDDS), to enhance patient convenience and treatment adherence. In 2021, the company was acquired by Boryung to strengthen its CNS portfolio and expand its specialized manufacturing capabilities. Today, it operates as a key subsidiary, providing both internal product development and contract development and manufacturing (CDMO) services for complex dosage forms.
- Therapeutic areas
- UrologyNeurology
- Modalities
- Small molecule
- Industry
- Pharma
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
BoryungSamjin PharmCelltrion
Beyond the preview
Go deeper on Corepharm Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Corepharm Bio.